Page last updated: 2024-10-28

hydroxyurea and Vasospasm, Intracranial

hydroxyurea has been researched along with Vasospasm, Intracranial in 2 studies

Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nath, AF1
Kanodia, AK1
Nair, P1
Ramkumar, PG1
Barbosa, MD1
Arthur, AS1
Louis, RH1
MacDonald, T1
Polin, RS1
Gazak, C1
Kassell, NF1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Cerebral Aneurysms: a Retrospective Study on the Experience in Our Hospital With a Comparative Analysis Between the Different Techniques Used in Its Treatment[NCT04792944]247 participants (Actual)Observational2007-01-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for hydroxyurea and Vasospasm, Intracranial

ArticleYear
Reversible cerebral vasoconstriction syndrome (RCVS): a transient condition being underdiagnosed?
    BMJ case reports, 2016, Mar-07, Volume: 2016

    Topics: Aged; Brain; Clopidogrel; Female; Headache; Humans; Hydroxyurea; Magnetic Resonance Angiography; Tic

2016
The novel 5-lipoxygenase inhibitor ABT-761 attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage.
    Neurosurgery, 2001, Volume: 49, Issue:5

    Topics: Animals; Basilar Artery; Disease Models, Animal; Enzyme Inhibitors; Hydroxyurea; Lipoxygenase Inhibi

2001